Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION USP

Last updated on 2018-01-19 History
Report ID 25312
Drug Identification Number 02258218
Brand name IRINOTECAN HYDROCHLORIDE INJECTION
Common or Proper name IRINOTECAN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1x5mL
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-31
Estimated end date
Actual end date 2018-01-18
Shortage status Resolved
Updated date 2018-01-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-01-19 French Compare
v10 2018-01-19 English Compare
v9 2017-12-14 French Compare
v8 2017-12-14 English Compare
v7 2017-11-23 French Compare
v6 2017-11-23 English Compare
v5 2017-11-23 English Compare
v4 2017-10-17 English Compare
v3 2017-10-11 French Compare
v2 2017-10-11 English Compare
v1 2017-10-11 English Compare

Showing 1 to 11 of 11